【TATA健康(01255.HK)预计中期股东应占亏损不超过150万港元】智通财经APP讯,TATA健康(01255.HK)发布公告,董事会谨此澄清,经对集团截至2026年6月30日止六个月的最新未经审核综合财务报表及目前可得的其他资料进行刊发后审阅后,公司发现盈利警告公告中存在轻微文书错误,预期集团于报告期间的公司拥有人应占亏损将由约
1239.9万港元减少至不超过150万港元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.